MUTARS tibial plateau M-O-M cemented TiN - Uncoated knee tibia prosthesis, metallic Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

mutars tibial plateau m-o-m cemented tin - uncoated knee tibia prosthesis, metallic

life healthcare pty ltd - 32832 - uncoated knee tibia prosthesis, metallic - tibial component of a coupled total knee replacement. constructed from cocrmo alloy with titanium nitride coating to prevent allergic reactions. m-o-m components are coupled by the metal-on-metal connecting mechanism. it is recommended to use the m-o-m components in case of an extra-articular resection.connects to various tibial stems & spacers as part of a modular universal tumour and revision system (mutars). a component of the mutars system intended to replace the tibial articulating surfaces of the knee. primary indication for the use of the mutars systems is after bone resection because of a tumour. further indications for the use of the mutars systems are massive bone loss such as in morbus gorham or for the revision arthroplasty and for the prosthetic treatment in case of fractures, pseudarthrosis and arthrosis.

MUTARS tibial plateau M-O-M cementless TiN - Coated knee tibia prosthesis Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

mutars tibial plateau m-o-m cementless tin - coated knee tibia prosthesis

life healthcare pty ltd - 34198 - coated knee tibia prosthesis - tibial component of a coupled total knee replacement. constructed from cocrmo alloy with titanium nitride coating to prevent allergic reactions. m-o-m components are coupled by the metal-on-metal connecting mechanism. it is recommended to use the m-o-m components in case of an extra-articular resection. connects to various tibial stems & spacers as part of a modular universal tumor and revision system (mutars). a component of the mutars system intended to replace the tibial articulating surfaces of the knee. primary indication for the use of the mutars systems is after bone resection because of a tumour. further indications for the use of the mutars systems are massive bone loss such as in morbus gorham or for the revision arthroplasty and for the prosthetic treatment in case of fractures, pseudarthrosis and arthrosis

MUTARS Distal Femur M-O-M TiN - Uncoated knee femur prosthesis Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

mutars distal femur m-o-m tin - uncoated knee femur prosthesis

life healthcare pty ltd - 32831 - uncoated knee femur prosthesis - constructed from cocrmo alloy with titanium nitride coated to prevent allergic reactions. m-o-m components are coupled by the metal-on-metal connecting mechanism. it is recommended to use the m-o-m components in case of an extra-articular resection. connects to various femoral stems and extension pieces as part of a modular universal tumor and revision system (mutars). a component of the mutars system intended to replace the distal extra-articular femoral section of the knee. primary indication for the use of the mutars systems is after bone resection because of a tumour. further indications for the use of the mutars systems are massive bone loss such as in morbus gorham or for the revision arthroplasty and for the prosthetic treatment in case of fractures, pseudarthrosis and arthrosis

MUTARS GenuX femoral component cementless TiN - Trabeculated knee femur prosthesis Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

mutars genux femoral component cementless tin - trabeculated knee femur prosthesis

life healthcare pty ltd - 33863 - trabeculated knee femur prosthesis - femoral component of a constrained knee replacement prosthesis. composed of cocrmo coated with tin. connects to various femoral stems as part of a modular universal tumour and revision system (mutars). a component of the mutars system intended to replace the femoral articulating surfaces of the knee. primary indication for the use of the mutars systems is after bone resection because of a tumour. further indications for the use of the mutars systems are massive bone loss such as in morbus gorham or for the revision arthroplasty and for the prosthetic treatment in case of fractures, pseudarthrosis and arthrosis.

MUTARS GenuX femoral component TiN cemented - Uncoated knee femur prosthesis Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

mutars genux femoral component tin cemented - uncoated knee femur prosthesis

life healthcare pty ltd - 32831 - uncoated knee femur prosthesis - femoral component of a constrained knee replacement prosthesis. composed of cocrmo coated with tin. connects to various femoral stems as part of a modular universal tumor and revision system (mutars. a component of the mutars system intended to replace the femoral articulating surfaces of the knee. primary indication for the use of the mutars systems is after bone resection because of a tumour. further indications for the use of the mutars systems are massive bone loss such as in morbus gorham or for the revision arthroplasty and for the prosthetic treatment in case of fractures, pseudarthrosis and arthrosis

MUTARS humerus head - Humeral head prosthesis Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

mutars humerus head - humeral head prosthesis

life healthcare pty ltd - 48088 - humeral head prosthesis - humeral head replacement prosthesis. composed of tial6v4. connects to a humerus cap and extension piece as part of a proximal or total humeral replacement in a modular universal tumor and revision system (mutars). a component of the mutars system intended to replace the humeral head as part of a proximal or total humerus reconstruction. primary indication for the use of the mutars systems is after bone resection because of a tumour. further indications for the use of the mutars systems are massive bone loss such as in morbus gorham or for the revision arthroplasty and for the prosthetic treatment in case of fractures, pseudarthrosis and arthrosis.

MUTARS RS metaphyseal component - Revision uncoated hip femur prosthesis Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

mutars rs metaphyseal component - revision uncoated hip femur prosthesis

life healthcare pty ltd - 33178 - revision uncoated hip femur prosthesis - prosthesis to replace the metaphyseal section of the femur. composed of tial6v4. connects to a proximal femoral component and extension piece or stem as part of hip revision or total femoral replacement in a modular universal tumor and revision system (mutars). a component of the mutars system intended to replace the metaphyseal part of the proximal femur. primary indication for the use of the mutars systems is after bone resection because of a tumour. further indications for the use of the mutars systems are massive bone loss such as in morbus gorham or for the revision arthroplasty and for the prosthetic treatment in case of fractures, pseudarthrosis and arthrosis

MUTARS RS metaphyseal component HA - Body femoral extension Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

mutars rs metaphyseal component ha - body femoral extension

life healthcare pty ltd - 33714 - body femoral extension - prosthesis to replace the metaphyseal section of the femur. composed of tial6v4 coated with hydroxyapatite. connects to a proximal femoral component and extension piece or stem as part of hip revision or total femoral replacement in a modular universal tumor and revision system (mutars). a component of the mutars system intended to replace the metaphyseal part of the proximal femur. primary indication for the use of the mutars systems is after bone resection because of a tumour. further indications for the use of the mutars systems are massive bone loss such as in morbus gorham or for the revision arthroplasty and for the prosthetic treatment in case of fractures, pseudarthrosis and arthrosis.

Roclanda Unjoni Ewropea - Bulgaru - EMA (European Medicines Agency)

roclanda

santen oy - latanoprost, netarsudil mesilate - glaucoma, open-angle; ocular hypertension - Офталмологични - roclanda is indicated for the reduction of elevated intraocular pressure (iop) in adult patients with primary open-angle glaucoma or ocular hypertension for whom monotherapy with a prostaglandin or netarsudil provides insufficient iop reduction.

Roclanda Unjoni Ewropea - Norveġiż - EMA (European Medicines Agency)

roclanda

santen oy - latanoprost, netarsudil mesilate - glaucoma, open-angle; ocular hypertension - Øyemidler - roclanda is indicated for the reduction of elevated intraocular pressure (iop) in adult patients with primary open-angle glaucoma or ocular hypertension for whom monotherapy with a prostaglandin or netarsudil provides insufficient iop reduction.